-transparent.png){kind=logo}
Pregraft treatment of chicks with 6 mercaptopurine-palladium complex (6-MP-Pd) resulted in a 16% survival of skin allografts incompatible at the major histocompatibility locus B. These incompatible grafts survived beyond 16 weeks postgrafting and showed profuse feather growth. No form of postgraft treatment was necessary. All nontreated incompatible grafts were rejected prior to 4 weeks postgrafting with no evidence of feather development. The same treatment, however, did not significantly suppress rejection of B-system compatible grafts which differed at minor histocompatibility loci. The rate of feather growth in successful B-system compatible grafts was significantly enhanced by the 6-MP-Pd treatment through 2 weeks postgrafting. Though the drug appears to affect the cellular immune system, the humoral immune response was unaffected as evidenced by a high antibody titer following turkey erythrocyte challenge.
R C Fanguy, and
L K Misra, and
R W Lewis
February 1972,
Transplantation,
R C Fanguy, and
L K Misra, and
R W Lewis
February 2017,
Blood,
R C Fanguy, and
L K Misra, and
R W Lewis
January 2011,
Chimerism,
R C Fanguy, and
L K Misra, and
R W Lewis
March 1973,
Transplantation proceedings,
R C Fanguy, and
L K Misra, and
R W Lewis
February 1998,
Immunology today,
R C Fanguy, and
L K Misra, and
R W Lewis
February 1993,
Transplantation proceedings,
R C Fanguy, and
L K Misra, and
R W Lewis
September 1991,
Investigative ophthalmology & visual science,
R C Fanguy, and
L K Misra, and
R W Lewis
June 1994,
Transplant immunology,
R C Fanguy, and
L K Misra, and
R W Lewis
March 1988,
Immunology letters,
